miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1.
Yang MengXiaoyan HuShasha LiXinyi ZengLei QiuMingtian WeiZiqing WangJunhong HanPublished in: BMC cancer (2020)
Our results show a novel link between miR-203 and IRS-1, and reveal the importance of strict control of IRS - 1 by miR-203 in the progression of PCa, suggesting miR-203 may act as a promising target for the diagnosis and treatment of advanced PCa.